Inhibition of Lipolysis by Mercaptoacetate and Etomoxir Specifically Sensitize Drug-Resistant Lung Adenocarcinoma Cell to Paclitaxel
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Lipolysis by Mercaptoacetate and Etomoxir Specifically Sensitize Drug-Resistant Lung Adenocarcinoma Cell to Paclitaxel
Authors
Keywords
Adenocarcinoma of the lung, Drug metabolism, Adenocarcinoma cells, Cell metabolism, Glucose metabolism, Oleates, Glycolysis, Malonates
Journal
PLoS One
Volume 8, Issue 9, Pages e74623
Publisher
Public Library of Science (PLoS)
Online
2013-09-12
DOI
10.1371/journal.pone.0074623
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers
- (2013) P E Lønning et al. ONCOGENE
- Role of SUMO-Specific Protease 2 in Reprogramming Cellular Glucose Metabolism
- (2013) Shuang Tang et al. PLoS One
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
- (2012) Y-C Shen et al. BRITISH JOURNAL OF CANCER
- Regulation of lipogenesis by cyclin-dependent kinase 8–mediated control of SREBP-1
- (2012) Xiaoping Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?
- (2012) Elisa Giovannetti et al. PHARMACOGENOMICS
- Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
- (2012) José Manuel Tirado-Vélez et al. PLoS One
- Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
- (2011) Y. Zhao et al. CANCER RESEARCH
- Altered HepG2 cell models using etomoxir versus tert-butylhydroperoxide
- (2011) Véronique Vincourt et al. CELL BIOLOGY AND TOXICOLOGY
- Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress
- (2011) K. Zaugg et al. GENES & DEVELOPMENT
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- Reactive oxygen species-independent rapid initiation of mitochondrial apoptotic pathway by chelerythrine
- (2011) Takeshi Funakoshi et al. TOXICOLOGY IN VITRO
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
- (2010) Jian-Bin Wang et al. CANCER CELL
- Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress
- (2010) Tanja Hadzic et al. FREE RADICAL BIOLOGY AND MEDICINE
- Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
- (2010) Qiang-ling Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Sugar-free approaches to cancer cell killing
- (2010) N El Mjiyad et al. ONCOGENE
- Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
- (2009) Ismael Samudio et al. JOURNAL OF CLINICAL INVESTIGATION
- A Quantitative Proteomics Analysis of Subcellular Proteome Localization and Changes Induced by DNA Damage
- (2009) François-Michel Boisvert et al. MOLECULAR & CELLULAR PROTEOMICS
- Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir
- (2008) Emma Hernlund et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started